The image shows a HER2 IHC stained tissue specimen of invasive breast cancer with AI HER2 overlay in the invasive regions only and HER2 IHC staining with no ai overlay in the DCIS / LCIS regions of the tissue sample.

Breast IHC AI 2.0

An automated, AI-based decision-support tool that standardizes scoring of HER2, ER, PR, and Ki67 IHC in breast cancer cases.

Breast IHC AI 2.0 Read More »